ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,002Medicare Part D Prescriptions Filled, Including Refills

Rank: 165 out of 1121

$549K Total Retail Price of All Prescriptions

Rank: 349 out of 1121

408 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 408 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

27% of this provider’s 408 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 12,411 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
OMEPRAZOLE 635 574 1 6
HYDROCODONE-ACETAMINOPHEN 596 478 S3 2 3
SIMVASTATIN 579 543 3 1
LEVOTHYROXINE SODIUM 480 421 4 2
AMLODIPINE BESYLATE 479 426 5 5
LISINOPRIL 404 391 6 4
METOPROLOL SUCCINATE 390 368 7 23
FUROSEMIDE 348 310 8 7
METOPROLOL TARTRATE 290 256 9 9
ZOLPIDEM TARTRATE 289 262 10 19
METFORMIN HCL 283 251 11 8
HYDROCHLOROTHIAZIDE 272 254 12 10
WARFARIN SODIUM 206 186 13 11
POTASSIUM CHLORIDE 201 190 14 12
GLIMEPIRIDE 194 174 15 34
SERTRALINE HCL 188 148 16 21
PRAVASTATIN SODIUM 178 153 17 14
TAMSULOSIN HCL 162 162 18 32
MELOXICAM 159 147 19 22
GABAPENTIN 158 121 20 13
CLOPIDOGREL 143 122 21 27
LOSARTAN POTASSIUM 140 111 22 17
CIPROFLOXACIN HCL 131 111 23 57
PANTOPRAZOLE SODIUM 127 98 24 29
AZITHROMYCIN 127 110 24 44
DIGOXIN 124 94 26 59
KLOR-CON 10 122 105 27 69
ATORVASTATIN CALCIUM 121 117 28 15
RAMIPRIL 121 112 28 74
CLONIDINE HCL 115 108 30 39
PLAVIX 109 95 31 42
LIPITOR 101 101 32 106
LOVASTATIN 100 93 33 26
CITALOPRAM HBR 99 95 34 18
BENAZEPRIL HCL 95 86 35 41
CYCLOBENZAPRINE HCL 92 83 R 36 83
LOSARTAN-HYDROCHLOROTHIAZIDE 87 67 37 46
DONEPEZIL HCL 87 87 37 35
LANTUS 83 59 39 52
CRESTOR 82 82 40 28
PAROXETINE HCL 82 78 40 58
AMITRIPTYLINE HCL 79 55 R 42 61
CYMBALTA 72 62 43 50
ALLOPURINOL 69 69 44 30
ATENOLOL 69 60 44 16
TRIAMTERENE-HCTZ 69 67 44 38
AVODART 67 67 47 249
FLUTICASONE PROPIONATE 65 58 48 36
LANTUS SOLOSTAR 65 60 48 109
CARVEDILOL 61 38 50 20
ADVAIR DISKUS 61 44 50 64
MIRTAZAPINE 59 59 52 56
LISINOPRIL-HYDROCHLOROTHIAZIDE 59 59 52 31
MORPHINE SULFATE ER 59 40 S2 52 87
CARBIDOPA-LEVODOPA 58 58 55 118
JANTOVEN 53 53 56 146
TORSEMIDE 52 41 57 155
PROAIR HFA 50 40 58 48
LACTULOSE 50 50 58 132
PREDNISONE 50 48 58 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.